| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179063A2 Genes expressed in hippocampus |
| 02/13/2002 | EP1179062A2 Nucleic acids and proteins with p53 activity and altered tetramerization domains |
| 02/13/2002 | EP1179061A1 Methods for treating tumors using antiangiogenic compounds |
| 02/13/2002 | EP1179058A1 Cell concentration and lysate clearance using paramagnetic particles |
| 02/13/2002 | EP1179055A1 Novel phytochelatin synthases and uses therefor |
| 02/13/2002 | EP1179053A1 Telophase enucleated oocytes for nuclear transfer |
| 02/13/2002 | EP1179052A2 Serine proteases |
| 02/13/2002 | EP1179049A2 (ex vivo) expansion of mammalian hematopoietic stem cells |
| 02/13/2002 | EP1179048A2 CULTURES OF INSECT CELLS WHICH REPRODUCE AT 37 oC, METHOD FOR OBTAINING SAID CULTURES AND THEIR USES |
| 02/13/2002 | EP1179046A1 Lineage-restricted precursor cells isolated from mouse neural tube and mouse embryonic stem cells |
| 02/13/2002 | EP1179022A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179021A1 Human gaba b receptor 1 promoters |
| 02/13/2002 | EP1179019A2 Immunogenic peptides derived from mage and the use thereof |
| 02/13/2002 | EP1179018A1 Interaction between the vhl tumour suppressor and hypoxia inducible factor, and assay methods relating thereto |
| 02/13/2002 | EP1179017A1 Expression of heparin-binding protein in recombinant mammalian cells |
| 02/13/2002 | EP1179015A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179007A1 Self-assembling biomolecular structures |
| 02/13/2002 | EP1179003A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
| 02/13/2002 | EP1179002A1 Methods using mechanisms of action of aroa |
| 02/13/2002 | EP1178832A1 Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics |
| 02/13/2002 | EP1178829A1 Human monoclonal antibody |
| 02/13/2002 | EP1178823A2 New vaccine formulations - 1 |
| 02/13/2002 | EP1178822A2 New vaccine formulations - 2 |
| 02/13/2002 | EP1178817A2 Molecular interactions in haematopoietic cells |
| 02/13/2002 | EP1178812A2 Conditioned cell culture medium compositions and methods of use |
| 02/13/2002 | EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response |
| 02/13/2002 | EP1178721A2 Process of rapid variety-independent plant transformation |
| 02/13/2002 | EP1007671B1 Fanconi-gen ii |
| 02/13/2002 | EP0812859B1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
| 02/13/2002 | EP0791051B1 Neural cultures |
| 02/13/2002 | EP0779359B1 Method of culturing avian cells |
| 02/13/2002 | EP0759069B1 Beta taipoxin as a cell growth factor and method |
| 02/13/2002 | CN1335891A Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them |
| 02/13/2002 | CN1335888A OPG fusion protein compositions and methods |
| 02/13/2002 | CN1335886A Glufosinate tolerant rice |
| 02/13/2002 | CN1335884A Interluckin 17-like receptor protein |
| 02/13/2002 | CN1335389A Fermenting culture process of produicng Cordyceps extract |
| 02/12/2002 | US6346656 Increasing resistance of plants or algal cells by genetically engineering a unicellular green alga resistant to porphyrin herbicides |
| 02/12/2002 | US6346608 MecB |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346606 A protein; diagnosis and therapy for tumor diseases, central nervous system diseases, glioblastomas, and breast cancer |
| 02/12/2002 | US6346414 Transposition assembly for gene transfer in eukaryotes |
| 02/12/2002 | US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor |
| 02/12/2002 | US6346398 Ribozyme or antisense nucleic acid which inhibits synthesis, gene expression and/or stability of messenger rna encoding the flt-1 receptor of human or mouse receptor; treatment of diabetic retinopathy; angiogenesis inhibitors |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346388 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
| 02/12/2002 | US6346373 Whole cell assay for cathepsin K activity |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | CA2215303C Sertoli cells as transplantation facilitator for cell transplantation |
| 02/12/2002 | CA2068204C Latency associated peptides and uses therefor |
| 02/12/2002 | CA1341339C Arg-serpin human plasminogen activator inhibitor designated pai-2 |
| 02/09/2002 | CA2354726A1 Sodium ion-driven chloride/bi-carbonate exchanger |
| 02/07/2002 | WO2002010768A2 Model for alzheimer's disease and other neurodegenerative diseases |
| 02/07/2002 | WO2002010766A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors |
| 02/07/2002 | WO2002010762A1 A novel assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound |
| 02/07/2002 | WO2002010416A1 IMPROVED VIRUS LIKE PARTICLES BASED ON SMALL ENVELOPE PROTEIN FROM HEPATITIS B (HBsAg-S) |
| 02/07/2002 | WO2002010414A2 Expression of biologically active polypeptides in duckweed |
| 02/07/2002 | WO2002010408A1 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same |
| 02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | WO2002010405A2 A human disintegrin protein |
| 02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 02/07/2002 | WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | WO2002010394A2 Nucleic acids, by means of which plants with altered metabolite content can be produced |
| 02/07/2002 | WO2002010393A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | WO2002010392A2 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010384A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
| 02/07/2002 | WO2002010383A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
| 02/07/2002 | WO2002010382A2 Trp8, trp9 and trp10, markers for cancer |
| 02/07/2002 | WO2002010381A1 Novel protein inhibitor of apoptosis proteins |
| 02/07/2002 | WO2002010379A2 Modified cea and uses thereof |
| 02/07/2002 | WO2002010378A2 Antisense modulation of ptp1b expression |
| 02/07/2002 | WO2002010376A1 HUMAN II TYPE 5α-REDUCTASE PROMOTER GENE AND USE THEREOF |
| 02/07/2002 | WO2002010372A1 Method of producing functional protein domains |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010362A2 Methods of controlling gene expression and gene silencing |
| 02/07/2002 | WO2002010355A2 Alpha-amylase mutants with altered stability |
| 02/07/2002 | WO2002010353A1 Lipo-viro-particle complexes, preparation method and uses |
| 02/07/2002 | WO2002010352A2 Production of human monoclonal antibodies |
| 02/07/2002 | WO2002010351A2 Autologous connective tissues, methods for the production thereof and their use |
| 02/07/2002 | WO2002010349A1 Cultured epidermal cell sheet, laminated cultured skin sheet and process for producing the same |
| 02/07/2002 | WO2002010348A2 Tissue implant for cartilage repair |
| 02/07/2002 | WO2002010347A2 Directed differentiation of embryonic cells |
| 02/07/2002 | WO2002010346A2 Insulin producing cell-line obtained by electrofusion |
| 02/07/2002 | WO2002010345A2 Autologous bio-matrix from mammalian liver |
| 02/07/2002 | WO2002010344A2 Synchronised arabidopsis cell suspensions and uses thereof |
| 02/07/2002 | WO2002010337A2 Method of cloning porcine animals |
| 02/07/2002 | WO2002010334A2 Dna element promoter of transcription activity, active in human cells and general method for adjusting the activity thereof |
| 02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010196A2 Identification of a novel glutamine transporter |
| 02/07/2002 | WO2002009790A1 Collagen membrane arranged at macromolecular level |
| 02/07/2002 | WO2002009650A2 Methods and compositions for the repair and/or regeneration of damaged myocardium |